SuppreMol GmbH is now a part of Baxalta
Baxalta is a leading biopharmaceutical company advancing innovative therapies in hematology, immunology, and oncology. See more at: www.Baxalta.com
The SuppreMol site in Martinsried, located in the southwest of the Bavarian capital Munich (Germany) brings a strong immunological heritage with a vast knowledge of Fc-receptors to the R&D of Baxalta.
A team of 24 highly motivated scientist and clinical experts (including administration and support) focusses on the biology of human Fc-receptors especially soluble FcγRIIb receptors. These receptors play a pivotal role in human immunity and autoimmune diseases.
In addition to SM101 (lead product, recombinant soluble human FcγRIIb), SuppreMol also works on anti-FcγRIIb antibodies, for the treatment of autoimmune diseases (SM2x1 project) and allergic reactions (SM301 project).
Am Klopferspitz 19a
82152 Martinsried / Munich
Tel: +49-89-30 90 50 680